Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Wave Life Sciences Ltd.

    NASDAQ: WVE · Real-Time Price · USD
    6.84
    -0.11 (-1.58%)
    At close: Jun 16, 2025, 3:59 PM
    6.62
    -3.22%
    Pre-market: Jun 17, 2025, 04:39 AM EDT

    Wave Life Sciences Statistics

    Share Statistics

    Wave Life Sciences has 154.13M shares outstanding. The number of shares has increased by 25.32% in one year.

    Shares Outstanding

    n/a
    		 154.13M

    Shares Change (YoY)

    n/a
    		 25.32%

    Shares Change (QoQ)

    n/a
    		 0.63%

    Owned by Institutions (%)

    n/a
    		 97.83%

    Shares Floating

    n/a
    		 123.09M

    Failed to Deliver (FTD) Shares

    n/a
    		 1

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 15.03M, so 9.75% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 15.03M

    Short % of Shares Out

    n/a
    		 9.75%

    Short % of Float

    n/a
    		 13.35%

    Short Ratio (days to cover)

    n/a
    		 15

    Valuation Ratios

    The PE ratio is -17.63 and the forward PE ratio is -6.57. Wave Life Sciences's PEG ratio is -0.6.

    PE Ratio

    n/a
    		 -17.63

    Forward PE

    n/a
    		 -6.57

    PS Ratio

    n/a
    		 15.79

    Forward PS

    n/a
    		 2.7

    PB Ratio

    n/a
    		 8.16

    P/FCF Ratio

    n/a
    		 -11.26

    PEG Ratio

    n/a
    		 -0.6
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Wave Life Sciences.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.89, with a Debt / Equity ratio of 0.12.

    Current Ratio

    n/a
    		 2.89

    Quick Ratio

    n/a
    		 2.89

    Debt / Equity

    n/a
    		 0.12

    Debt / EBITDA

    n/a
    		 -0.25

    Debt / FCF

    n/a
    		 -0.17

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $377,358.89

    Profits Per Employee

    n/a
    		 $-338,006.97

    Employee Count

    n/a
    		 287

    Asset Turnover

    n/a
    		 0.31

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by 14.19% in the last 52 weeks. The beta is -1.05, so Wave Life Sciences's price volatility has been lower than the market average.

    Beta

    n/a
    		 -1.05

    52-Week Price Change

    n/a
    		 14.19%

    50-Day Moving Average

    n/a
    		 6.53

    200-Day Moving Average

    n/a
    		 10.01

    Relative Strength Index (RSI)

    n/a
    		 51.82

    Average Volume (20 Days)

    n/a
    		 1,450,068

    Income Statement

    In the last 12 months, Wave Life Sciences had revenue of 108.3M and earned -97.01M in profits. Earnings per share was -0.7.

    Revenue

    n/a
    		 108.3M

    Gross Profit

    n/a
    		 108.3M

    Operating Income

    n/a
    		 -110.4M

    Net Income

    n/a
    		 -97.01M

    EBITDA

    n/a
    		 -101.74M

    EBIT

    n/a
    		 -110.4M

    Earnings Per Share (EPS)

    n/a
    		 -0.7
    Full Income Statement

    Balance Sheet

    The company has 302.08M in cash and 25.4M in debt, giving a net cash position of 276.67M.

    Cash & Cash Equivalents

    n/a
    		 302.08M

    Total Debt

    n/a
    		 25.4M

    Net Cash

    n/a
    		 276.67M

    Retained Earnings

    n/a
    		 -1.12B

    Total Assets

    n/a
    		 288.34M

    Working Capital

    n/a
    		 170.61M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -151.03M and capital expenditures -938K, giving a free cash flow of -151.96M.

    Operating Cash Flow

    n/a
    		 -151.03M

    Capital Expenditures

    n/a
    		 -938K

    Free Cash Flow

    n/a
    		 -151.96M

    FCF Per Share

    n/a
    		 -1.1
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of -101.94% and -89.57%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 -101.94%

    Pretax Margin

    n/a
    		 -89.57%

    Profit Margin

    n/a
    		 -89.57%

    EBITDA Margin

    n/a
    		 -93.94%

    EBIT Margin

    n/a
    		 -101.94%

    FCF Margin

    n/a
    		 -140.32%

    Dividends & Yields

    WVE does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for WVE is $22, which is 221.6% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $22

    Price Target Difference

    n/a
    		 221.6%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 12
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -0.74

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist